Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

被引：26

作者：

Brochez, Lieve ^{[1
,2
,3
,4
]}

Meireson, Annabel ^{[2
,3
]}

Chevolet, Ines ^{[2
]}

Sundahl, Nora ^{[3
,5
]}

Ost, Piet ^{[3
,4
,5
]}

Kruse, Vibeke ^{[3
,6
]}

机构：

[1] Ghent Univ Hosp, Dept Dermatol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium

[2] Ghent Univ Hosp, Dermatol Res Unit, Corneel Heymanslaan 10, B-9000 Ghent, Belgium

[3] ION Ghent, Ghent, Belgium

[4] CRIG, Ghent, Belgium

[5] Ghent Univ Hosp, Dept Radiotherapy, Corneel Heymanslaan 10, B-9000 Ghent, Belgium

[6] Ghent Univ Hosp, Dept Med Oncol, Corneel Heymanslaan 10, B-9000 Ghent, Belgium

来源：

NATURE COMMUNICATIONS | 2018年 / 9卷

关键词：

D O I：

10.1038/s41467-018-05047-1

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页数：3

共 7 条

[1] Biomarker: Predictive or Prognostic? [J].

Ballman, Karla V. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (33) :3968-+

[2] The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy [J].

Brochez, Lieve ;

Chevolet, Ines ;

Kruse, Vibeke .

EUROPEAN JOURNAL OF CANCER, 2017, 76 :167-182

[3] Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma [J].

Chevolet, Ines ;

Speeckaert, Reinhart ;

Schreuer, Max ;

Neyns, Bart ;

Krysko, Olga ;

Bachert, Claus ;

Van Gele, Mireille ;

van Geel, Nanja ;

Brochez, Lieve .

JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13

[4] Predictors of responses to immune checkpoint blockade in advanced melanoma [J].

Jacquelot, N. ;

Roberti, M. P. ;

Enot, D. P. ;

Rusakiewicz, S. ;

Ternes, N. ;

Jegou, S. ;

Woods, D. M. ;

Sodre, A. L. ;

Hansen, M. ;

Meirow, Y. ;

Sade-Feldman, M. ;

Burra, A. ;

Kwek, S. S. ;

Flament, C. ;

Messaoudene, M. ;

Duong, C. P. M. ;

Chen, L. ;

Kwon, B. S. ;

Anderson, A. C. ;

Kuchroo, V. K. ;

Weide, B. ;

Aubin, F. ;

Borg, C. ;

Dalle, S. ;

Beatrix, O. ;

Ayyoub, M. ;

Balme, B. ;

Tomasic, G. ;

Di Giacomo, A. M. ;

Maio, M. ;

Schadendorf, D. ;

Melero, I. ;

Dreno, B. ;

Khammari, A. ;

Dummer, R. ;

Levesque, M. ;

Koguchi, Y. ;

Fong, L. ;

Lotem, M. ;

Baniyash, M. ;

Schmidt, H. ;

Svane, I. M. ;

Kroemer, G. ;

Marabelle, A. ;

Michiels, S. ;

Cavalcanti, A. ;

Smyth, M. J. ;

Weber, S. ;

Eggermont, A. M. ;

Zitvogel, L. .

NATURE COMMUNICATIONS, 2017, 8

[5] Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms [J].

Schefold, Joerg C. ;

Zeden, Jan-Philip ;

Fotopoulou, Christina ;

von Haehling, Stephan ;

Pschowski, Rene ;

Hasper, Dietrich ;

Volk, Hans-Dieter ;

Schuett, Christine ;

Reinke, Petra .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (06) :1901-1908

[6] Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma [J].

Sundahl, Nora ;

De Wolf, Katrien ;

Kruse, Vibeke ;

Meireson, Annabel ;

Reynders, Dries ;

Goetghebeur, Els ;

Van Gele, Mireille ;

Speeckaert, Reinhart ;

Hennart, Benjamin ;

Brochez, Lieve ;

Ost, Piet .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (04) :906-915

[7] IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer Patients [J].

Wang, Weili ;

Huang, Lei ;

Jin, Jian-Yue ;

Jolly, Shruti ;

Zang, Yong ;

Wu, Huanmei ;

Yan, Li ;

Pi, Wenhu ;

Li, Lang ;

Mellor, Andrew L. ;

Kong, Feng-Ming .

CANCER RESEARCH, 2018, 78 (03) :809-816

← 1 →